Arjan van de Loosdrecht
Overview
Explore the profile of Arjan van de Loosdrecht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gisriel S, Aakash F, Bennett J, Hasserjian R, Loghavi S, DeZern A, et al.
Arch Pathol Lab Med
. 2025 Mar;
PMID: 40059041
Context.—: Standardized bone marrow reporting specifically for myelodysplastic syndromes/neoplasms (MDS) is currently lacking in the literature and much needed in practice. Objective.—: To propose a standardized approach to MDS evaluation...
2.
Rombaut D, Sandmann S, Tekath T, Crouch S, de Graaf A, Smith A, et al.
Hemasphere
. 2025 Jan;
9(1):e70073.
PMID: 39850648
Lower risk (LR) myelodysplastic syndromes (MDS) are heterogeneous hematopoietic stem and progenitor disorders caused by the accumulation of somatic mutations in various genes including epigenetic regulators that may produce convergent...
3.
Kern W, Westers T, Bellos F, Bene M, Bettelheim P, Brodersen L, et al.
Cytometry B Clin Cytom
. 2022 Nov;
104(1):51-65.
PMID: 36416672
Background: Myelodysplastic syndromes (MDS) represent a diagnostic challenge. This prospective multicenter study was conducted to evaluate pre-defined flow cytometric markers in the diagnostic work-up of MDS and chronic myelomonocytic leukemia...
4.
Kern W, van de Loosdrecht A
Cytometry B Clin Cytom
. 2022 Nov;
104(1):10-11.
PMID: 36409089
No abstract available.
5.
Rozema J, van Roon E, Vogelzang L, Kibbelaar R, Veeger N, van de Loosdrecht A, et al.
Eur J Haematol
. 2022 Jun;
109(4):381-387.
PMID: 35753043
Objectives: Infections are a major cause of morbidity and mortality in patients with myelodysplastic syndromes (MDS). The objective of the MINDSET study was to evaluate haematologists' management of infection prevention...
6.
van der Velden V, Preijers F, Johansson U, Westers T, Dunlop A, Porwit A, et al.
Cytometry B Clin Cytom
. 2021 Dec;
104(1):15-26.
PMID: 34894176
Background: Flow cytometry (FCM) aids the diagnosis and prognostic stratification of patients with suspected or confirmed myelodysplastic syndrome (MDS). Over the past few years, significant progress has been made in...
7.
Janssen J, Lowenberg B, Manz M, Bargetzi M, Biemond B, Borne P, et al.
Cancers (Basel)
. 2021 Feb;
13(4).
PMID: 33562393
Treatment results of AML in elderly patients are unsatisfactory. We hypothesized that addition of tosedostat, an aminopeptidase inhibitor, to intensive chemotherapy may improve outcome in this population. After establishing a...
8.
Hanekamp D, Ngai L, Janssen J, van de Loosdrecht A, Ossenkoppele G, Cloos J
Blood
. 2020 Nov;
137(12):1694-1697.
PMID: 33171485
No abstract available.
9.
Hanekamp D, Bachas C, van de Loosdrecht A, Ossenkoppele G, Cloos J
Pathology
. 2019 Dec;
52(2):289-291.
PMID: 31883670
No abstract available.
10.
Itzykson R, Fenaux P, Bowen D, Cross N, Cortes J, de Witte T, et al.
Hemasphere
. 2019 Nov;
2(6):e150.
PMID: 31723789
Chronic myelomonocytic leukemia (CMML) is a disease of the elderly, and by far the most frequent overlap myelodysplastic/myeloproliferative neoplasm in adults. Aside from the chronic monocytosis that remains the cornerstone...